[Federal Register Volume 64, Number 46 (Wednesday, March 10, 1999)]
[Notices]
[Page 11925]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-5911]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The contract proposals and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the contract proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel, Animal Model Testing of 
Tuberculosis Drugs.
    Date: March 31, 1999.
    Time: 8:30 A.M. to 5:00 P.M.
    Agenda: To review and evaluate contract proposals.
    Place: 6003 Executive Blvd., Solar Bldg.--Room 3B05, Rockville, 
MD 20852.
    Contact Person: Allen C. Stoolmiller, Scientific Review 
Administrator, Scientific Review Program, Division of Extramural 
Activities, NIAID, NIH, Solar Building, Room 4C05, 6003 Executive 
Boulevard MSC 7610, Bethesda, MD 20892-7610, 301-496-7966.

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: March 4, 1999.
LaVerne Y. Stringfield,
Committee Management Officer, NIH.
[FR Doc. 99-5911 Filed 3-9-99; 8:45 am]
BILLING CODE 4140-01-M